Keyphrases
Community-acquired Pneumonia
100%
Retrospective Cohort Study
36%
Confidence Interval
27%
Sputum
25%
Comorbidity
23%
Hospitalized Patients
20%
Hazard Ratio
19%
Risk Factors
18%
Bacterial Meningitis
18%
Prospective Cohort Study
18%
COVID-19
18%
Type 1 Diabetes Mellitus (T1DM)
16%
Adult Patients
15%
90-day Mortality
14%
C-reactive Protein
14%
Denmark
12%
30-day Mortality
12%
CURB-65
11%
Pneumonia
10%
Severe Infection
10%
Lower Respiratory Tract Infection
9%
Disease Severity
9%
Acute Lower Respiratory Tract Infection
9%
Neutrophil Accumulation
9%
Atypical Pathogens
9%
Validation Cohort
9%
Cerebrospinal Fluid Pleocytosis
9%
Improved Outcomes
9%
Do-not-resuscitate Orders
9%
At Discharge
9%
Leukocyte Count
9%
Non-infectious
9%
Readmission Risk
9%
Nervous System Diseases
9%
Corticosteroid Treatment
9%
Albumin
9%
Penicillin
9%
Blood Glucose
9%
Glycemic Gap
9%
Neutrophil-to-lymphocyte Ratio
9%
Platelet-to-lymphocyte Ratio
9%
Relative Risk
9%
Global Initiatives
9%
Lactate
9%
Lactate Level
9%
Population-based
9%
Aerobic Respiration
9%
Viral Community
9%
Mortality Factors
9%
Severe Acute Respiratory Syndrome Coronavirus 2 Variants
9%
Medicine and Dentistry
Community-Acquired Pneumonia
63%
Retrospective Cohort Study
27%
Diabetes Mellitus
22%
Biological Marker
20%
Cohort Analysis
19%
Prospective Cohort Study
18%
Omicron Coronavirus Variant
18%
Infection
16%
Hazard Ratio
15%
Sputum
14%
Intensive Care Unit
14%
Leukocyte
13%
C Reactive Protein
13%
Pathogen
12%
Prevalence
11%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Lower Respiratory Tract Infection
9%
Disease Severity
9%
Blood Glucose
9%
Glycemic
9%
COVID-19
9%
Neutrophil
9%
Lymphocyte
9%
Central Nervous System Disease
9%
Lung Infection
9%
Ventricle of Heart
9%
Pleocytosis
9%
Platelet
9%
Staphylococcal Pneumonia
9%
Cerebrospinal Fluid
9%
Bacterial Meningitis
9%
Consumer
9%
Cohort Study
9%
Methicillin Resistant Staphylococcus Aureus
9%
Influenza A
9%
Influenza B
9%
Disease
7%
Cerebral Ventricle
7%
Hyperglycemia
6%
Cell Count
6%
Hospital Mortality
5%
